CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Planned sale See Remarks sold 103,376 shares at $13.26 ($1,370,249)
- 4 Open-market sale Director sold 12,888 shares at $12.99 ($167,465)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Marketing Officer acquired 17,832 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 35,663 shares (grant or award)
- 4 Grant or award See Remarks acquired 95,399 shares (grant or award)
- 4 Grant or award See Remarks acquired 23,776 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 2,252 shares at $10.85 ($24,438)
Page 5 of 28 · 558 filings